Companies that own Mabion S.A.
Generali PTE SA
1,490,545
10.86%
94,510
2.71%
05/07/2018
Nationale-Nederlanden PTE SA
912,390
6.65%
0
0.32%
04/26/2018
Investors TFI SA
794,566
5.79%
127,500
5.56%
04/26/2018
PZU Asset Management SA
165,749
1.21%
-35,713
0.59%
06/30/2017
Templeton Asset Management Ltd. (Hong Kong)
156,250
1.13%
0
0.03%
06/30/2018
MetLife PTE SA
95,000
0.69%
-25,483
0.1%
12/31/2016
Union Investment TFI SA
49,716
0.36%
-8,456
0.46%
06/30/2017
ESALIENS TFI SA
42,000
0.31%
-106,922
0.37%
06/30/2017
NN Investment Partners Towarzystwo Funduszy Inwestycyjnych SA
41,701
0.3%
14,739
0.01%
06/30/2017
Noble Funds TFI SA
22,989
0.17%
22,989
0.31%
06/30/2017
| Address |
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki LD 95
Poland
|
|
Employees
|
- |
| Website |
http://www.mabion.eu |
| Updated |
07/08/2019 |
| Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology. |
